Barrett's Esophagus: Emerging Knowledge and Management Strategies

about

Management strategies of Barrett's esophagus Healthcare Cost of Over-Diagnosis of Low-Grade Dysplasia in Barrett's Esophagus.Improvement of atropine on esophagogastric junction observation during sedative esophagogastroduodenoscopy.

P2860

Q38062526-AE58FAEB-C19B-4A79-9630-14813431D642 Q38760580-6631F4D4-9B88-46B0-BC7D-EB6A7F89F8E6 Q41027631-385E7392-0BA2-4CFC-9A2E-A356E9454E9D

P2860

Barrett's Esophagus: Emerging Knowledge and Management Strategies

Item

http://www.wikidata.org/entity/Q36014649

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@ast

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@en

type

Item

label

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@ast

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@en

prefLabel

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@ast

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@en

P1476

Barrett's Esophagus: Emerging Knowledge and Management Strategies

@en

P2093

Atul Bhardwaj

http://www.w3.org/2001/XMLSchema#string

Douglas B Stairs

http://www.w3.org/2001/XMLSchema#string

Haresh Mani

http://www.w3.org/2001/XMLSchema#string

Thomas J McGarrity

http://www.w3.org/2001/XMLSchema#string

P2860

The oesophagus lined with gastric mucous membrane

CDX1 is an important molecular mediator of Barrett's metaplasia

Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.

Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus

Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence

Prostaglandins and cancer

Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus

P304

814146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/814146

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225372368

http://www.w3.org/2001/XMLSchema#string

P698

22701199

http://www.w3.org/2001/XMLSchema#string

P932

3369502

http://www.w3.org/2001/XMLSchema#string

Barrett's Esophagus: Emerging Knowledge and Management Strategies

about

P2860

P2860

Barrett's Esophagus: Emerging Knowledge and Management Strategies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P932